 "alkemlabs.com")
Aklem Laboratories has moved higher by 11% to Rs 2,468, also its all-time high on BSE in intra-day trade, after the company said that it has received Establishment Inspection Report (EIR) from the US health regulator for its Baddi facility.
“The United States Food and Drug Administration (USFDA) has issued an EIR for the Company's manufacturing facility located at Baddi, India which was inspected from 11th September, 2017 to 15th September, 2017,” Aklem Laboratories said in a statement.
In response to the two Form 483 observations issued by the US FDA, the Company had submitted a detailed corrective
“The United States Food and Drug Administration (USFDA) has issued an EIR for the Company's manufacturing facility located at Baddi, India which was inspected from 11th September, 2017 to 15th September, 2017,” Aklem Laboratories said in a statement.
In response to the two Form 483 observations issued by the US FDA, the Company had submitted a detailed corrective
